Arunjyoti Bio [ABVL] vs PDS [PDSL] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Arunjyoti Bio Ventures Ltd. wins in 4 metrics, PDS Ltd. wins in 15 metrics, with 0 ties. PDS Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Arunjyoti Bio Ventures Ltd. PDS Ltd. Better
P/E Ratio (TTM) 55.46 37.65 PDS Ltd.
Price-to-Book Ratio 4.38 2.38 PDS Ltd.
Debt-to-Equity Ratio 71.24 70.40 PDS Ltd.
PEG Ratio -0.53 -0.52 PDS Ltd.
EV/EBITDA 26.00 15.46 PDS Ltd.
Profit Margin (TTM) -6.61% 0.82% PDS Ltd.
Operating Margin (TTM) 8.92% 2.44% Arunjyoti Bio Ventures Ltd.
EBITDA Margin (TTM) 8.92% 2.44% Arunjyoti Bio Ventures Ltd.
Return on Equity -5.63% 9.14% PDS Ltd.
Return on Assets (TTM) -3.06% 3.31% PDS Ltd.
Free Cash Flow (TTM) $-44.22M $-1.80B Arunjyoti Bio Ventures Ltd.
Dividend Yield N/A 0.94% N/A
1-Year Return -31.33% -31.12% PDS Ltd.
Price-to-Sales Ratio (TTM) 6.11 0.31 PDS Ltd.
Enterprise Value $1.56B $43.13B PDS Ltd.
EV/Revenue Ratio 6.04 0.33 PDS Ltd.
Gross Profit Margin (TTM) 100.00% 22.68% Arunjyoti Bio Ventures Ltd.
Revenue per Share (TTM) $1 $930 PDS Ltd.
Earnings per Share (Diluted) $-0.09 $7.61 PDS Ltd.
Beta (Stock Volatility) 0.21 -0.05 PDS Ltd.

Arunjyoti Bio Ventures Ltd. vs PDS Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Arunjyoti Bio Ventures Ltd.-2.60%-3.75%-17.84%-32.54%-32.03%-34.98%
PDS Ltd.0.50%0.20%7.88%1.45%-13.94%-19.24%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Arunjyoti Bio Ventures Ltd.-31.33%-68.54%228.82%202.16%326.72%195.77%
PDS Ltd.-31.12%-8.66%52.91%755.61%536.34%536.34%

Performance & Financial Health Analysis: Arunjyoti Bio Ventures Ltd. vs PDS Ltd.

MetricABVLPDSL
Market Information
Market Cap i₹1.58B₹40.46B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,838,634124,606
90 Day Avg. Volume i1,898,848575,541
Last Close₹5.25₹303.30
52 Week Range₹5.05 - ₹12.71₹246.05 - ₹433.90
% from 52W High-58.69%-30.10%
All-Time High₹30.07 (Jan 15, 2024)₹666.00 (Nov 13, 2023)
% from All-Time High-82.54%-54.46%
Growth Metrics
Quarterly Revenue Growth0.05%0.02%
Quarterly Earnings Growth0.05%-0.21%
Financial Health
Profit Margin (TTM) i-0.07%0.01%
Operating Margin (TTM) i0.09%0.02%
Return on Equity (TTM) i-0.06%0.09%
Debt to Equity (MRQ) i71.2470.40
Cash & Liquidity
Book Value per Share (MRQ)₹1.93₹120.55
Cash per Share (MRQ)₹0.01₹74.31
Operating Cash Flow (TTM) i₹-12,115,000₹-574,170,000
Levered Free Cash Flow (TTM) i₹-18,215,000₹1.57B
Dividends
Last 12-Month Dividend Yield iN/A0.94%
Last 12-Month Dividend iN/A₹3.35

Valuation & Enterprise Metrics Analysis: Arunjyoti Bio Ventures Ltd. vs PDS Ltd.

MetricABVL (Apr 26, 2026)PDSL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i55.4637.65
Forward P/E iN/A25.81
PEG Ratio i-0.53-0.52
Price to Sales (TTM) i6.110.31
Price to Book (MRQ) i4.382.38
Market Capitalization
Market Capitalization i₹1.58B₹40.46B
Enterprise Value i₹1.56B₹43.13B
Enterprise Value Metrics
Enterprise to Revenue i6.040.33
Enterprise to EBITDA i26.0015.46
Risk & Other Metrics
Beta i0.21-0.05
Book Value per Share (MRQ) i₹1.93₹120.55

Financial Statements Comparison: Arunjyoti Bio Ventures Ltd. vs PDS Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricABVL (2025)PDSL (2025)
Revenue/Sales i278.84M121.00B
Cost of Goods Sold i114.29M101.25B
COGS % of Revenue i41.0%83.7%
Gross Profit i164.55M19.75B
Gross Margin i59.0%16.3%
Research & Development iN/AN/A
Operating Income (EBIT) i19.68M3.88B
Operating Margin i7.1%3.2%
EBITDA i52.95M4.88B
EBITDA Margin i19.0%4.0%
Pre-Tax Income i-3.41M2.68B
Pre-Tax Income % of Revenue i-1.2%2.2%
Income Tax i14.81M271.15M
Income Tax % of Revenue i5.3%0.2%
Net Income (Profit) i-18.22M2.41B
Profit Margin i-6.5%2.0%

Balance Sheet & Liquidity Metrics

MetricABVL (2025)PDSL (2025)
Cash & Equivalents i5.92M4.35B
Total Current Assets i147.98M35.12B
Total Current Assets % of Revenue i53.1%29.0%
Total Current Liabilities i52.90M27.94B
Total Current Liabilities % of Revenue i19.0%23.1%
Long-Term Debt i214.50M1.92B
Long-Term Debt % of Revenue i76.9%1.6%
Total Shareholders Equity i323.80M17.16B
Retained Earnings i-30.59M8.11B
Retained Earnings % of Revenue i-11.0%6.7%
Property, Plant & Equipment i71.31M2.96B

Cash Flow Statement Comparison

MetricABVL (2025)PDSL (2025)
Operating Cash Flow i-12.12M-574.17M
Operating Cash Flow % of Revenue i-4.3%-0.5%
Capital Expenditures i-58.72M-909.35M
Free Cash Flow i-44.22M-1.80B
FCF Margin i-15.9%-1.5%
Debt Repayment iN/A-41.67M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricABVLPDSL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i186.38M141.22M
Float Shares i11.37M26.91M
% Held by Insiders i68.86%71.87%
% Held by Institutions i0.00%5.08%
% Held by Public i31.14%23.05%

Dividend Analysis & Yield Comparison: Arunjyoti Bio Ventures Ltd. vs PDS Ltd.

MetricABVLPDSL
Last 12-Month Dividend iN/A₹3.35
Last 12-Month Dividend Yield iN/A0.94%
3-Year Avg Annual Dividend iN/A₹4.12
3-Year Avg Dividend Yield iN/A0.48%
3-Year Total Dividends iN/A₹12.35
Ex-Dividend DateN/AOct 31, 2025